These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22408707)

  • 1. Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid.
    Walmsley N; Hampton P
    J Dermatol Case Rep; 2011 Dec; 5(4):74-6. PubMed ID: 22408707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between COVID-19 vaccination and bullous pemphigoid - a case series and literature review.
    Wan V; Chen D; Shiau CJ; Jung GW
    SAGE Open Med Case Rep; 2022; 10():2050313X221131868. PubMed ID: 36274858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid in adolescence.
    Patsatsi A; Kyriakou A; Werth VP
    Pediatr Dermatol; 2019 Mar; 36(2):184-188. PubMed ID: 30569520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five Cases.
    Hali F; Araqi L; Marnissi F; Meftah A; Chiheb S
    Cureus; 2022 Mar; 14(3):e23127. PubMed ID: 35425676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Bullous Rash Apparently Triggered by Meningococcal and Rotavirus Vaccines in an Infant: Focus on Infantile Bullous Pemphigoid.
    Neri I; Evangelista V; Guglielmo A; Sechi A; Virdi A
    Dermatopathology (Basel); 2021 Feb; 8(1):33-36. PubMed ID: 33672215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies.
    Phan K; Goyal S; Murrell DF
    Australas J Dermatol; 2019 Feb; 60(1):23-28. PubMed ID: 30141189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination.
    Shanshal M
    Cureus; 2022 Jun; 14(6):e26383. PubMed ID: 35911257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series.
    Cowan TL; Huang C; Murrell DF
    Front Med (Lausanne); 2022; 9():1117176. PubMed ID: 36703892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furosemide-induced bullous pemphigoid: case report and review of literature.
    Lee JJ; Downham TF
    J Drugs Dermatol; 2006 Jun; 5(6):562-4. PubMed ID: 16774111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine.
    Nida SS; Tobon GJ; Wilson M; Chauhan K
    Cureus; 2022 Sep; 14(9):e29786. PubMed ID: 36340561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
    Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood bullous pemphigoid developed after the first vaccination.
    Baykal C; Okan G; Sarica R
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):348-50. PubMed ID: 11174412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and presumptive triggers of localized bullous pemphigoid.
    Ständer S; Kasperkiewicz M; Thaçi D; Schmidt E; Zillikens D; Vorobyev A; Ludwig RJ
    J Dermatol; 2021 Aug; 48(8):1257-1261. PubMed ID: 33998059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature.
    Attaway A; Mersfelder TL; Vaishnav S; Baker JK
    J Dermatol Case Rep; 2014 Mar; 8(1):24-8. PubMed ID: 24748908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.
    Mai Y; Nishie W; Sato K; Hotta M; Izumi K; Ito K; Hosokawa K; Shimizu H
    Front Immunol; 2018; 9():542. PubMed ID: 29706950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyshidrosiform Bullous Pemphigoid: Case Reports and Review.
    Cohen PR
    Cureus; 2020 Jan; 12(1):e6630. PubMed ID: 32064205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA bullous pemphigoid: a distinct blistering disorder. Case report and review of the literature.
    Jones RR; Goolamali SK
    Br J Dermatol; 1980 Jun; 102(6):719-25. PubMed ID: 7000138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.